Stock listing

OTC:GBLX GB Sciences, Inc. Stock

Follow GB Sciences, Inc. into a list and get an email when it puts out news.

Share price · OTC:GBLX

$0.0002 USD +0.0001 (+100.0%)

Close on Nov 20, 2026

Past year -33.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.0001 – $0.0002 USDNov 20, 2026
Volume
3,800 sharesNov 20, 2026
Market cap
$81,414 USDAt the close on Nov 20, 2026 · price × 407.1M shares outstanding
52-week range
$0.0001 – $0.5002 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$7 USDMedian day 14,105 shares · 6 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
GB Sciences, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:GBLX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.0002+0.0001+100.0%$0.0001$0.0002$0.00013,800
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000193,654
$0.0001-0.0001-50.0%$0.0002$0.0002$0.00011,083,165
$0.0002+0.0001+100.0%$0.0001$0.0002$0.00012,100
$0.0001-0.0001-50.0%$0.0001$0.0002$0.000165,459
$0.00020.00000.0%$0.0002$0.0002$0.00021,993
$0.00020.00000.0%$0.0002$0.0002$0.0002130,000
$0.00020.00000.0%$0.0002$0.0002$0.000215,973
$0.0002+0.0001+100.0%$0.0001$0.0002$0.00012,000
$0.00010.00000.0%$0.0001$0.0001$0.00018,113
$0.00010.00000.0%$0.0001$0.0001$0.000139,566
$0.00010.00000.0%$0.0001$0.0001$0.000143,250
$0.00010.00000.0%$0.0001$0.0001$0.000116,340
$0.00010.00000.0%$0.0001$0.0001$0.00012,056
$0.00010.00000.0%$0.0001$0.0001$0.000125,500
$0.00010.00000.0%$0.0001$0.0001$0.0001500
$0.00010.00000.0%$0.0001$0.0001$0.00014,000
$0.00010.00000.0%$0.0001$0.0001$0.000124,901
$0.00010.00000.0%$0.0001$0.0001$0.00011,800
$0.00010.00000.0%$0.0001$0.0001$0.00011,000
$0.00010.00000.0%$0.0001$0.0001$0.000121,000
$0.00010.00000.0%$0.0001$0.0001$0.00016,125
$0.00010.00000.0%$0.0001$0.0001$0.00011,245
$0.00010.00000.0%$0.0001$0.0001$0.000114,350
$0.00010.00000.0%$0.0001$0.0001$0.000116,565
$0.00010.00000.0%$0.0001$0.0001$0.0001750
$0.00010.00000.0%$0.0001$0.0001$0.000117,300
$0.00010.00000.0%$0.0001$0.0001$0.000119,405
$0.00010.00000.0%$0.0001$0.0001$0.000118,398
$0.00010.00000.0%$0.0001$0.0001$0.00017,325
$0.00010.00000.0%$0.0001$0.0001$0.000113,860
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000117,483
$0.00010.00000.0%$0.0001$0.0015$0.0001108,000
$0.00010.00000.0%$0.0001$0.0001$0.0001950
$0.00010.00000.0%$0.0001$0.0001$0.0001378,393
$0.00010.00000.0%$0.0001$0.0001$0.00011,400
$0.00010.00000.0%$0.0001$0.0002$0.0001151,721
$0.0001-0.0001-50.0%$0.0001$0.0002$0.00011,169
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002500
$0.0002+0.0001+100.0%$0.0002$0.0002$0.00024,145
$0.00010.00000.0%$0.0001$0.0001$0.00012,732
$0.0001-0.0001-50.0%$0.0001$0.0002$0.000196,103
$0.00020.00000.0%$0.0002$0.0002$0.000278,500
$0.00020.00000.0%$0.0002$0.0002$0.000246,746
$0.00020.00000.0%$0.0002$0.0002$0.000227,971
$0.00020.00000.0%$0.0002$0.0002$0.00023,500
$0.00020.00000.0%$0.0002$0.0016$0.000212,881
$0.0002-0.0001-33.3%$0.0002$0.0003$0.000231,665
$0.00030.00000.0%$0.0001$0.0003$0.000135,992
$0.00030.00000.0%$0.0003$0.0003$0.000327,542
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.000320,401
$0.00030.00000.0%$0.0003$0.0003$0.000362,600
$0.00030.00000.0%$0.0003$0.0003$0.0003275,761
$0.0003-0.0001-25.0%$0.0003$0.0003$0.000371,200
$0.0004+0.0001+33.3%$0.0003$0.0004$0.00031,600
$0.00030.00000.0%$0.0003$0.0003$0.00032,600
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.000370,000
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00032,018
$0.00030.00000.0%$0.0003$0.0003$0.0003500
$0.00030.00000.0%$0.0003$0.0003$0.000317,011

Splits

3 splits since 2004 · OTC:GBLX · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-50Consolidation
5-for-1Split
Ticker
OTC:GBLX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

All GB Sciences, Inc. news

GB Sciences, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
143 in all · newest Dec 22, 2022 · oldest 2017
Decks
4 decks · latest August 2024

Valuation

balance Jun 30, 2025 · price Nov 20, 2026

Enterprise value
$2.07M USD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
-0.46

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
GB Sciences, Inc. · OTC:GBLXUS$81,414US$2.07Mn/an/an/an/an/an/a-0.46
NKGen Biotech Inc. · OTC:NKGNUS$391,807US$38.58Mn/an/an/an/an/an/a0.88
Vaxil Bio Ltd. · TSXV:VXLUS$319,522−US$4,0711.2×n/an/a0.4×n/a0.0×-0.16
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
CNBX Pharmaceuticals Inc. · OTC:CNBXUS$160,577US$151,090n/an/an/an/an/an/a1.78
Fifty 1 Labs Inc. · OTC:FITYUS$118,532US$282,021n/a6,000×n/an/an/an/a-1.17
Lyra Therapeutics, Inc. · OTC:LYRAUS$53,246US$14.42Mn/a36.2×n/an/an/an/a0.67
Median of the othersUS$225,579US$73,5101.2×18.5×0.2×−382.1%0.0×1.14

Team and board

Officers

OfficerRole
Andrea Small-HowardChairman of the Scientific Advisory Board, Chief Science Officer and Director

Board

DirectorRole
Andrea Small-HowardChairman of the Scientific Advisory Board, Chief Science Officer and Director

Events

QuarterResultsShare move
Q1 2026Aug 12, 2025+200.0%
Q2 2025Nov 18, 2024 · After close
Q3 2024Feb 12, 2024 · After close+1.8%
Q2 2024Nov 20, 2023 · After close−11.4%
Q1 2024Aug 14, 2023 · After close+3.5%
Q3 2023Feb 3, 2023 · After close−1.4%
Q2 2023Nov 9, 2022 · After close−3.6%
Q1 2023Aug 11, 2022 · After close+5.9%
Q4 2022Jun 30, 2022−14.4%
Q3 2022Feb 11, 2022−5.9%
All 14 quarters
QuarterResultsShare move
Q2 2022Nov 15, 2021−7.8%
Q1 2022Jul 6, 2021−10.3%
Q4 2021Jun 30, 2021−10.0%
Q3 2021Feb 16, 2021+25.5%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2024)Investor deck15 slidesAugust 2024
Investor Presentation (March 2018)Investor deck16 slidesMar 19, 2018
Investor Presentation (March 2018)Investor deck16 slidesMar 16, 2018
Investor Presentation (March 2018)Investor deck19 slidesMar 12, 2018

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue0003.12M3.12M3.46M2.51M000
Cost of revenue62461.7K70.5K47.4K4.00M3.25M782.7K416.0K177.1K70.0K
Gross profit-624-61.7K-70.5K-47.4K-126.0K208.5K1.73M-416.0K-177.0K0
Research and development261.6K490.3K821.3K3521.54K458.8K0000
Selling, general and administrative1.16M1.67M1.87M2.00M5.68M13.4M19.6M8.93M6.96M7.97M
Operating income-1.42M-1.67M-1.87M-2.00M-12.0M-13.2M-17.8M-8.93M-6.96M-7.97M
Depreciation and amortization62461.7K70.5K47.4K258.7K250.2K804.8K416.0K177.1K69.1K
EBITDA-1.42M-1.61M-1.80M-1.95M-11.8M-12.9M-17.0M-8.52M-6.78M-7.90M
Interest expense219.0K178.7K474.8K1.28M1.63M4.94M5.18M901.1K105.2K230
Income before tax-1.36M-4.13M-147.0K-3.33M-4.75M-21.5M-23.2M-10.1M-7.08M-7.97M
Income tax278.3B2.63T-1.80M1.45M86.8K526.1K4.83M727.9K-202.0K-250.7K
Net income-1.36M-4.13M-531.0K-3.73M-12.4M-23.7M-23.0M-9.91M-6.77M-7.72M
Earnings per share, basic-0.00-0.01-0.00-0.01-0.05-0.11-0.17-0.13-0.15-0.26

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash and equivalents12.0K109.9K233.9K793.0K151.8K227.8K3.58M2.69M34.8K0
Short-term investments00000
Receivables5.34M488.3K667.1K067.9K50.0K
Inventory1.45M2.14M1.05M89.0K00
Current assets103.4K309.5K327.8K3.54M7.00M3.47M7.25M2.95M207.5K240.4K
Property, plant and equipment25.0K37.8K10.5M13.8M8.64M1.95M913.6K
Goodwill-42.8B-2.22T-1.71T-1.70T-1.82T1.40M000
Total assets103.4K352.3K2.55M10.8M14.4M30.0M24.0M13.0M2.44M1.45M
Accounts payable2.01M1.98M1.66M1.41M1.32M1.37M371.9K176.2K902.1K677.2K
Current liabilities5.10M4.76M3.94M8.60M10.9M6.71M1.92M675.6K2.26M984.6K
Long-term debt322.0K397.3K292.4K161.1K355.2K155.3K2.15M0
Total debt1.76M1.40M1.38M4.46M9.42M8.68M7.55M3.93M2.61M30.0K
Total liabilities5.42M4.76M4.33M12.3M14.4M12.9M8.42M4.60M4.41M1.21M
Shareholders' equity-5.31M-4.41M-1.78M-1.47M-88.5K8.30M12.7M8.33M-1.90M497.3K
Shares outstanding396.7M357.7M317.6M285.2M258.5M209.5M132.9M79.0M44.9M29.5M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations-975.7K-1.53M-1.87M-2.19M-4.48M-9.24M-12.2M-4.47M-3.56M-3.55M
Capital spending-2-31.6K-200.0K-292.7K-294.2K-10.6M-3.43M-3.05M-881.6K-937.7K
Free cash flow-975.7K-1.56M-2.07M-2.48M-4.77M-19.8M-15.7M-7.52M-4.45M-4.48M
Cash from investing320.0K-31.6K1.45M4.66M-538.8K-11.6M-5.40M-4.20M-859.1K-662.7K
Cash from financing557.8K1.43M-495.9K-1.48M4.99M17.5M18.5M11.3M4.46M3.87M
Dividends paid-2.86T0000
Share buybacks968.0K-809.2K0000
Change in cash-97.9K-124.0K-911.7K641.3K-30.3K-3.35M886.7K2.66M34.8K3.87M

Open Financials

Cap table

Built by 6ix from GB Sciences, Inc.’s releases

Common shares
407,071,028
Fully diluted
407,071,028

Fully diluted

LineShares
Common shares407,071,028

Share count over time

CountShares
Nov 22, 2026407,071,028

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Craig Ellins
Other companies: One World Pharma, Inc. (CEO and CFO, Director · Mar 3, 2020 – Mar 3, 2020 · Past)
CEO, Director · Mar 2, 2017 – Jun 16, 2017 · Past
John C PossChief Executive Officer, Director · Jul 11, 2018 – Jul 27, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about GB Sciences, Inc.